Literature DB >> 23063175

Model of excellence in Rheumatology Day Hospitals in Spain: the HD-Reumatolex project.

José Andrés Román Ivorra1, Raimon Sanmarti, Eduardo Collantes-Estévez, Luis Carreño Pérez, Lourdes Betegón.   

Abstract

OBJECTIVES: Biologics have shown greater efficacy than traditional treatments in patients with rheumatoid arthritis, although some cannot be administered on an outpatient basis. Day hospitalization requires the patient to attend the hospital for a few hours to receive those treatments that cannot be administered on an outpatient basis or that do not justify admission to hospital. Few studies have analyzed the situation of Rheumatology Day Hospitals (RDH) in Spain. The HD-Reumatolex project aims to evaluate the situation of Spanish RDHs in terms of strategy, training, management, and quality of care.
MATERIAL AND METHODS: The project was based on a "model of excellence in RDH" design, which made it possible to perform a comparative analysis (benchmarking) of 21 Rheumatology Departments. The 19 criteria evaluated were divided into 3 categories: Strategic processes, Key processes, and Support processes.
RESULTS: The lowest mean scores were recorded for follow-up of clinical practice guidelines/recommendations and existence of a quality plan (Strategic processes), criteria for training among RDH professionals (Support processes), and admission and discharge (Key processes). Five RDH achieved the benchmark when the position obtained by the RDH in Key processes was plotted against the one obtained in Strategic processes and Support processes. One RDH emerged as a clear leader in the comparison.
CONCLUSIONS: None of the RDH obtained the total maximum score at the category level or at the total results level, thus revealing room for improvement in the attainment of excellence for all the participating centers.
Copyright © 2012 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23063175     DOI: 10.1016/j.reuma.2012.07.001

Source DB:  PubMed          Journal:  Reumatol Clin        ISSN: 1699-258X


  1 in total

1.  An estimate of the cost of administering intravenous biological agents in Spanish day hospitals.

Authors:  Joan Miquel Nolla; Esperanza Martín; Pilar Llamas; Javier Manero; Arturo Rodríguez de la Serna; Manuel Francisco Fernández-Miera; Mercedes Rodríguez; José Manuel López; Alexandra Ivanova; Belén Aragón
Journal:  Ther Clin Risk Manag       Date:  2017-03-14       Impact factor: 2.423

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.